Bone Marrow TransplantationBone MarrowBone Marrow CellsHematopoietic Stem Cell TransplantationTransplantation, HomologousRadiusStem Cell TransplantationTransplantation, AutologousBone and BonesBone DensityGraft vs Host DiseaseTransplantation ConditioningHematopoietic Stem CellsStem CellsWhole-Body IrradiationTransplantation ChimeraPeripheral Blood Stem Cell TransplantationLiver TransplantationBone Marrow DiseasesGraft SurvivalTissue DonorsLeukemiaAnemia, AplasticBone Marrow PurgingHematologic NeoplasmsBone Marrow ExaminationBusulfanBone RemodelingHistocompatibility TestingHematopoiesisBone Marrow NeoplasmsTreatment OutcomeHistocompatibilityKidney TransplantationCyclophosphamideMice, Inbred C57BLRecurrenceCombined Modality TherapyCell DifferentiationTransplantation, IsogeneicTime FactorsRemission InductionLeukemia, Myeloid, AcuteImmunosuppressive AgentsMesenchymal Stem Cell TransplantationMultiple MyelomaRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveColony-Forming Units AssayCord Blood Stem Cell TransplantationRetrospective StudiesPrecursor Cell Lymphoblastic Leukemia-LymphomaGraft RejectionBone ResorptionCell TransplantationTransplantation ImmunologyAntigens, CD34Cells, CulturedMyelodysplastic SyndromesHepatic Veno-Occlusive DiseaseFlow CytometryT-LymphocytesSurvival AnalysisLymphoma, Non-HodgkinHeart TransplantationMelphalanLeukemia, MyeloidImmunosuppressionLymphocyte DepletionHematologic DiseasesAcute DiseaseAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem Cell MobilizationGranulocyte Colony-Stimulating FactorGraft vs Leukemia EffectHLA AntigensSurvival RateBone NeoplasmsLymphocyte TransfusionLung TransplantationDisease-Free SurvivalMyeloablative AgonistsSevere Combined ImmunodeficiencyFollow-Up StudiesGraft vs Tumor EffectChimeraCell SeparationMesenchymal Stromal CellsCytarabineOrgan TransplantationPancytopeniaCell LineageSpleenBone DevelopmentCyclosporineGraft vs Host ReactionLeukocyte TransfusionCytomegalovirus InfectionsChimerismBone Diseases